A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT(2019)
Key words
GSK3389404,chronic hepatitis B,hepatitis B virus,pharmacokinetics,first-time-in-human
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined